Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEbiquity Regulatory News (EBQ)

Share Price Information for Ebiquity (EBQ)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 41.00
Bid: 40.00
Ask: 42.00
Change: 0.00 (0.00%)
Spread: 2.00 (5.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 41.00
EBQ Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Appointment of CFO and Director

9 Sep 2016 07:00

RNS Number : 3758J
Ebiquity PLC
09 September 2016
 

Ebiquity Plc

("Ebiquity" or "the Company")

 

Appointment of Chief Financial Officer and Director

 

Ebiquity, the independent marketing analytics specialist, is pleased to announce the appointment of Andrew David Noble as Chief Financial Officer and a Director of the Board with immediate effect.

 

Andrew (aged 41) joined Ebiquity as Group Finance Director in February 2015 and has been a key member of the Company's senior management team with direct reporting lines from all finance functions.

 

Prior to joining Ebiquity, Andrew held a number of senior finance positions at Ipsos, a leading global market research company. Andrew qualified as a chartered accountant with PricewaterhouseCoopers in 2001 and graduated from the University of Oxford.

 

Andrew Beach remains an executive director until the handover of his responsibilities is completed on 14 October 2016.

 

Michael Karg, Group CEO of Ebiquity commented:

 

"I am proud we have appointed someone of Andrew's calibre from within Ebiquity. Andrew has worked across senior finance matters, including managing internal and external relationships with many key stakeholders. Given his extensive knowledge of the Company, the Board decided that Andrew is the natural successor to Andrew Beach. I have great confidence in Andrew's ability and I look forward to working more closely with him in his new role."

 

9 September 2016

 

Enquiries:

 

Ebiquity plc

Michael Karg (CEO)

 

 

Instinctif Partners

Matthew Smallwood

Guy Scarborough

 

020 7650 9600

 

 

 

020 7457 2020

Numis Securities Limited

Nick Westlake, Oliver Hardy (NOMAD)

Toby Adcock (Corporate Broker)

020 7260 1000

 

 

 

Additional information

 

Andrew Noble holds options under the Company's share option schemes over 60,000 ordinary shares of 25 pence each in the share capital of the Company ("Ordinary Shares") which are exercisable at 25 pence per Ordinary Share, representing approximately 0.08% of the total issued Ordinary Share capital of the Company and approximately 0.08% of the total voting rights in the share capital of the Company. Andrew does not hold any issued Ordinary Shares.

 

Andrew Noble has no current directorships and, save for Ipsos Retail Performance Limited, has not been a director of any other company during the previous five years.

 

Save as disclosed above, there is no information in relation to the appointment of Andrew Noble which is required to be disclosed pursuant to Rule 17 or Schedule Two paragraph (g) of the AIM Rules for Companies.

 

Note

 

The Ebiquity plc 2010 Employee Benefit Trust holds 4,200,000 issued Ordinary Shares to satisfy awards for the Company's senior management team. To date these awards have not been exercised and the trustee has agreed not to vote the Ordinary Shares held by it. As such 4,200,000 Ordinary Shares are treated as not carrying voting rights for the purposes of the City Code on Takeovers and Mergers.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOASSMFWAFMSESU
Date   Source Headline
25th Mar 20197:00 amRNSUnaudited Preliminary Results
1st Mar 20192:15 pmRNSTotal Voting Rights
22nd Feb 20193:55 pmRNSIssue of Shares
18th Feb 20197:00 amRNSHolding(s) in Company
12th Feb 20197:00 amRNSPre-close Trading Update
1st Feb 20197:00 amRNSTotal Voting Rights
23rd Jan 20194:50 pmRNSReplacement: Issue of Shares
23rd Jan 20193:25 pmRNSIssue of Shares
14th Jan 20193:35 pmRNSIssue of Shares
3rd Jan 20192:55 pmRNSIssue of Shares
2nd Jan 201911:40 amRNSDirectorate Change
2nd Jan 201911:40 amRNSCompletion of the disposal of the AdIntel division
2nd Jan 20197:00 amRNSTotal Voting Rights
14th Dec 20187:00 amRNSDirectorate Change
5th Dec 20181:45 pmRNSIssue of Shares
22nd Nov 20187:00 amRNSTrading Update
22nd Nov 20187:00 amRNSStatement re CMA final clearance notification
1st Nov 20187:00 amRNSTotal Voting Rights
24th Oct 20182:40 pmRNSIssue of Shares
23rd Oct 20182:05 pmRNSHolding(s) in Company
18th Oct 20184:06 pmRNSIssue of Shares
15th Oct 20187:00 amRNSIssue of Shares
11th Oct 20187:10 amRNSStatement re CMA Provisional Findings
10th Oct 201812:15 pmRNSDirectorate Change
4th Oct 20187:00 amRNSDirector/PDMR Shareholding
2nd Oct 20187:00 amRNSDirectorate Change
1st Oct 20187:00 amRNSTotal Voting Rights
27th Sep 20189:10 amRNSIssue of Shares
25th Sep 20187:00 amRNSDirectorate Change
25th Sep 20187:00 amRNSInterim Results
3rd Aug 20188:51 amRNSDirector/PDMR Shareholding
1st Aug 20187:00 amRNSTotal Voting Rights
27th Jul 20188:59 amRNSHolding(s) in Company
27th Jul 20188:55 amRNSHolding(s) in Company
27th Jul 20187:00 amRNSIssue of Shares and Director/PDMR Shareholdings
24th Jul 20187:00 amRNSInterim Trading Update
20th Jul 20185:00 pmRNSHolding(s) in Company
11th Jul 20183:05 pmRNSAward of options
6th Jul 20183:00 pmRNSIssue of Shares
25th Jun 20187:15 amRNSStatement re CMA Phase 2 referral
15th Jun 20187:00 amRNSPartnership with Snapchat to enhance measurement
13th Jun 20187:05 amRNSStatement re CMA review of disposal
1st Jun 20189:15 amRNSTotal Voting Rights
18th May 201812:20 pmRNSHolding(s) in Company
9th May 201812:11 pmRNSAGM Resolutions Passed
9th May 20187:00 amRNSIssue of Shares
1st May 20181:10 pmRNSHolding(s) in Company
27th Apr 20187:00 amRNSDirector/PDMR Shareholding
13th Apr 20187:00 amRNSAnnual Report
12th Apr 20182:15 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.